Sinopharm second dose administered to 2435 Chinese

The second dose of the Sinopharm vaccine has been administered to 2435 Chinese nationals in Sri Lanka so far.

According to the Health Ministry, the second dose was administered on 27 and 28 April.

A total of 2865 Chinese nationals employed in Sri Lanka received the first dose of the Sinopharm vaccine.

The Government commenced the vaccination of the Chinese manufactured coronavirus vaccine to Chinese nationals in Sri Lanka on the 5th of April.

The Colombo Port City was converted into a makeshift vaccination center where most of the Chinese were inoculated.

A stock of 600,000 Sinopharm vaccines gifted by China arrived in Sri Lanka on 31st March.

The Government announced that the vaccine will be used only to vaccinate Chinese national residing in Sri Lanka.

Health Minister Pavithra Wanniarachchi later announced that the Chinese Sinopharm vaccine will not be used on Sri Lankans until it is approved by the World Health Organisation (WHO) for emergency use.

It was thereafter informed that the WHO and the National Medicines Regulatory Authority (NMRA) have not approved the use of the vaccine.

Cabinet co-spokesman Minister Ramesh Pathirana said that the vaccine has been evaluated by the NMRA based on the information it has received so far and there is a delay in evaluating the Phase 4 clinical trial results.

“Phase 4 clinical trial results are not available in the English language and that is why the WHO has not given its recommendation to use the vaccine universally. The moment we get the approval we can use it on Sri Lankans as well,” he said.

Meanwhile, the People’s Movement for the Rights of Patients (PMRP) has filed a petition in the Supreme Court (SC) against the use of the Sinopharm vaccine in Sri Lanka, without proper approval.

The petition seeks an order preventing the Chinese manufactured vaccine from being administered in Sri Lanka without the consent of the National Medicines Regulatory Authority (NMRA). (Colombo Gazette)

LEAVE A REPLY

Please enter your comment!
Please enter your name here